ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR

Adagene to Participate in Upcoming Investor & Industry Conferences in November

09 نوفمبر 2021 15:05:03 بحسب Nasdaq GlobeNewswire

Adagene Unveils Preclinical Data from Two Transformative Antibody Programs at Upcoming American Society of Hematology (ASH) Annual Meeting

04 نوفمبر 2021 08:24:23 بحسب Nasdaq GlobeNewswire

Adagene to Participate in the Jefferies Virtual China Biotech Summit

21 أكتوبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates

26 أغسطس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)

19 أغسطس 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board

12 أغسطس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)

22 يوليو 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Announces Authorization of Share Repurchase Program up to US$20 Million

07 يوليو 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Announces Inclusion in FTSE Russell Indexes

16 يونيو 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Presents Clinical Data from NEObody™ Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting

19 مايو 2021 16:05:00 بحسب Nasdaq GlobeNewswire

Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021

13 أبريل 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Reports Full Year 2020 Financial Results and Provides Corporate Updates

31 مارس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Announces Clinical Advancement for ADG116

29 مارس 2021 06:45:00 بحسب Nasdaq GlobeNewswire

Adagene Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option

11 فبراير 2021 09:08:31 بحسب Nasdaq GlobeNewswire

Adagene Inc. Announces Pricing of Initial Public Offering

09 فبراير 2021 08:00:13 بحسب Nasdaq GlobeNewswire